JOURNEY MEDICAL CORPORATION - COMMON STOCK

Journey Medical Corporation Acquires Two FDA-Approved Topical Minocycline Products and Molecule Stabilizing Technology (MST)™ Franchise from VYNE Therapeutics, Inc.

13 1月 2022 07:00:01 条件 Nasdaq GlobeNewswire

Journey Medical Corporation Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights

10 12月 2021 08:00:00 条件 Nasdaq GlobeNewswire

Journey Medical Corporation to Present at the Benzinga Global Small Cap Conference

07 12月 2021 16:05:00 条件 Nasdaq GlobeNewswire

Journey Medical Corporation Introduces Expanded Board of Directors

29 11月 2021 08:00:01 条件 Nasdaq GlobeNewswire

Journey Medical Corporation Announces Closing of Initial Public Offering

16 11月 2021 16:01:00 条件 Nasdaq GlobeNewswire